Literature DB >> 18617685

In vivo osteoprogenitor potency of human stromal cells from different tissues does not correlate with expression of POU5F1 or its pseudogenes.

Nikolas Kaltz1, Alessia Funari, Sandra Hippauf, Bruno Delorme, Danièle Noël, Mara Riminucci, Volker R Jacobs, Thomas Häupl, Christian Jorgensen, Pierre Charbord, Christian Peschel, Paolo Bianco, Robert A J Oostendorp.   

Abstract

Expression of "stemness" markers is widely used as a predictor of stem cell properties of mesenchymal stem cells (MSC). Here, we show that bone marrow-derived (BM)-MSC show stem cell-like behavior in vivo; that is, they form ossicles with formation of bone, formation of adipocytes, and establishment of the murine hematopoietic microenvironment. Multipotent umbilical vein-derived stromal cells (UVSC), on the other hand, do not form bone, nor do they give rise to adipocytes in vivo. Despite these differences in stem-cell-like behavior, BM-MSC and UVSC express the two transcripts variants of POU5F1 at a similar level. Also, we found that in BM-MSC and UVSC, POU5F1 is detectable. However, more than 89% of the POU5F1 transcripts correspond to the POU5F1P1, -P3, or -P4 pseudogene. Despite low-level expression of POU5F1, we were unable to precipitate POU5F1 protein in either BM-MSC or UVSC. These results demonstrate that MSC stemness does not correlate to expression of POU5F1 transcripts or its pseudogenes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18617685     DOI: 10.1634/stemcells.2008-0304

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  16 in total

Review 1.  Unravelling the pluripotency paradox in fetal and placental mesenchymal stem cells: Oct-4 expression and the case of The Emperor's New Clothes.

Authors:  Jennifer M Ryan; Allison R Pettit; Pascale V Guillot; Jerry K Y Chan; Nicholas M Fisk
Journal:  Stem Cell Rev Rep       Date:  2013-08       Impact factor: 5.739

2.  Generation of functional mesenchymal stem cells from different induced pluripotent stem cell lines.

Authors:  Kim Hynes; Danijela Menicanin; Krzysztof Mrozik; Stan Gronthos; P Mark Bartold
Journal:  Stem Cells Dev       Date:  2014-02-07       Impact factor: 3.272

3.  Human Periosteal Derived Stem Cell Potential: The Impact of age.

Authors:  Concetta Ferretti; Guendalina Lucarini; Chiara Andreoni; Eleonora Salvolini; Novella Bianchi; Giovanni Vozzi; Antonio Gigante; Monica Mattioli-Belmonte
Journal:  Stem Cell Rev Rep       Date:  2015-06       Impact factor: 5.739

4.  Human umbilical cord blood-borne fibroblasts contain marrow niche precursors that form a bone/marrow organoid in vivo.

Authors:  Alice Pievani; Benedetto Sacchetti; Alessandro Corsi; Benedetta Rambaldi; Samantha Donsante; Valeria Scagliotti; Patrizia Vergani; Cristina Remoli; Andrea Biondi; Pamela G Robey; Mara Riminucci; Marta Serafini
Journal:  Development       Date:  2017-03-15       Impact factor: 6.868

5.  Derivation of mesenchymal stem cells from human induced pluripotent stem cells cultured on synthetic substrates.

Authors:  L G Villa-Diaz; S E Brown; Y Liu; A M Ross; J Lahann; J M Parent; P H Krebsbach
Journal:  Stem Cells       Date:  2012-06       Impact factor: 6.277

Review 6.  Human bone marrow mesenchymal stem cells: a systematic reappraisal via the genostem experience.

Authors:  Pierre Charbord; Erella Livne; Gerhard Gross; Thomas Häupl; Nuno M Neves; Pierre Marie; Paolo Bianco; Christian Jorgensen
Journal:  Stem Cell Rev Rep       Date:  2011-03       Impact factor: 5.739

Review 7.  Concise review: isoforms of OCT4 contribute to the confusing diversity in stem cell biology.

Authors:  Xia Wang; Jianwu Dai
Journal:  Stem Cells       Date:  2010-05       Impact factor: 6.277

Review 8.  Adipose-Derived Mesenchymal Stem Cells in Autoimmune Disorders: State of the Art and Perspectives for Systemic Sclerosis.

Authors:  Alexandre T J Maria; Marie Maumus; Alain Le Quellec; Christian Jorgensen; Danièle Noël; Philippe Guilpain
Journal:  Clin Rev Allergy Immunol       Date:  2017-04       Impact factor: 8.667

9.  Epigenetic silencing of Oct4 by a complex containing SUV39H1 and Oct4 pseudogene lncRNA.

Authors:  Michele Scarola; Elisa Comisso; Rhena Pascolo; Riccardo Chiaradia; Rosa Maria Marion; Claudio Schneider; Maria A Blasco; Stefan Schoeftner; Roberta Benetti
Journal:  Nat Commun       Date:  2015-07-09       Impact factor: 14.919

Review 10.  Potential application of cord blood-derived stromal cells in cellular therapy and regenerative medicine.

Authors:  Simone Maria Kluth; Teja Falk Radke; Gesine Kogler
Journal:  J Blood Transfus       Date:  2012-11-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.